High Outlier
DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

57844013001

Classification

Brand (ANDA)

Dosage Form

TABLET

Route

ORAL

Last Updated

1/1/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040422

On Market Since

2/6/2014

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+9.3%

1Y

+8.9%

3Y

+29.9%

5Y

+56.3%

All

+175.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.